Cargando…
SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK
Salt‐inducible kinase 2 (SIK2; also known as serine/threonine‐protein kinase SIK2) is overexpressed in several cancers and has been implicated in cancer progression. However, the mechanisms by which SIK2 regulates cancer cell motility, migration and metastasis in ovarian cancer have not been fully d...
Autores principales: | Shi, Xiu, Yu, Xuejiao, Wang, Juan, Bian, Shimin, Li, Qiutong, Fu, Fengqing, Zou, Xinwei, Zhang, Lin, Bast, Robert C., Lu, Zhen, Guo, Lingchuan, Chen, Youguo, Zhou, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251837/ https://www.ncbi.nlm.nih.gov/pubmed/35278271 http://dx.doi.org/10.1002/1878-0261.13208 |
Ejemplares similares
-
MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway
por: Li, Qiutong, et al.
Publicado: (2021) -
Heterozygous Mylk3 Knockout Mice Partially Recapitulate Human DCM With Heterozygous MYLK3 Mutations
por: Tougas, Carson L., et al.
Publicado: (2019) -
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
por: Lu, Zhen, et al.
Publicado: (2022) -
MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless
por: Zou, Xinwei, et al.
Publicado: (2020) -
Loss of the conserved PKA sites of SIK1 and SIK2 increases sleep need
por: Park, Minjeong, et al.
Publicado: (2020)